The podcast episodes discuss the potential of MDMA-assisted therapy and other psychedelic-based treatments for post-traumatic stress disorder (PTSD).

The episodes cover the promising clinical trial results, the FDA approval process, and the ongoing controversies surrounding allegations of research misconduct that could impact the timeline for approval.

The episodes also delve into the broader context of the psychedelic movement, the history of psychedelic research, and the philosophical and neuroscientific aspects of these treatments.

Examples of related episodes include DHS Sec. Mayorkas Explains the Asylum Plan, Psychedelic treatment for PTSD faces misconduct hurdle, and The Psychedelic Mind with Rick Doblin.